Home › Attention Deficit Hyperactivity Disorder › Mississippi › Jackson
Attention Deficit Hyperactivity Disorder clinical trials in Jackson, MS
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Jackson
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Jackson
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
RecruitingPhase 4
- Precise Research Centers, Flowood · 3 mi away
A Pilot Study of a Remote ADHD Monitoring Program
RecruitingHealthy volunteers welcome
- University of Mississippi Medical Center, Jackson
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Baltimore, MD4 studies
Other studies in Jackson
- Obesity8 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Lung Cancer6 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Prostate Cancer5 studies
- Breast Cancer4 studies
- Burkitt Lymphoma4 studies
- Type 2 Diabetes4 studies
- Schizophrenia4 studies
- Premature Birth4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.